Literature DB >> 2975540

Blastogenic responses to Pneumocystis carinii among patients with human immunodeficiency (HIV) infection.

D N Hagler1, G S Deepe, C L Pogue, P D Walzer.   

Abstract

Proliferative responses by human peripheral blood mononuclear cells and rat spleen cells were measured to Pneumocystis carinii in a blastogenic assay using organisms obtained from rat lungs and propagated in tissue culture as the antigen. Responses occurred only in subjects with known prior exposure to P. carinii and the magnitude of the response varied with the number of organisms present in the antigen preparation and days in culture. Healthy human adults showed higher proliferative responses to P. carinii than did patients with Class II (asymptomatic) or Class III (lymphadenopathy) human immunodeficiency virus (HIV) infection. No responses to the preparation were found among Class IV HIV patients with the acquired immunodeficiency syndrome, including those with prior episodes of P. carinii pneumonia or those receiving azidothymidine. Overall, the blastogenic responses obtained with P. carinii were similar to those obtained with tetanus toxoid and phytohemagglutinin, and correlated well with the number of circulating CD4 cells. The data suggest that the blastogenic assay using tissue culture-derived rat P. carinii is specific for the organism and should be helpful in studying the cellular immune responses in pneumocystosis among different human patient populations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2975540      PMCID: PMC1541708     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Latent Pneumocystis infection of rats, relapse, and chemotherapy.

Authors:  J K Frenkel; J T Good; J A Shultz
Journal:  Lab Invest       Date:  1966-10       Impact factor: 5.662

Review 2.  AIDS: immunopathogenic mechanisms and research strategies.

Authors:  A S Fauci
Journal:  Clin Res       Date:  1987-10

3.  Propagation of Pneumocystis carinii in vitro.

Authors:  L L Pifer; W T Hughes; M J Murphy
Journal:  Pediatr Res       Date:  1977-04       Impact factor: 3.756

4.  Lymphocyte changes during chronic administration of and withdrawal from corticosteroids: relation to Pneumocystis carinii pneumonia.

Authors:  P D Walzer; M LaBine; T J Redington; M T Cushion
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

5.  Comparison of rat, mouse, and human Pneumocystis carinii by immunofluorescence.

Authors:  P D Walzer; M E Rutledge
Journal:  J Infect Dis       Date:  1980-09       Impact factor: 5.226

6.  Cultivation of Pneumocystis carinii with WI-38 cells.

Authors:  M S Bartlett; P A Verbanac; J W Smith
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

7.  Growth and serial passage of Pneumocystis carinii in the A549 cell line.

Authors:  M T Cushion; P D Walzer
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

8.  The in vitro response of human lymphocytes to Pneumocystis carinii antigen.

Authors:  H G Herrod; W R Valenski; D R Woods; L L Pifer
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

9.  Comparison of histological and immunological techniques for detection of Pneumocystis carinii in rat bronchial lavage fluid.

Authors:  J E Milder; P D Walzer; J D Coonrod; M E Rutledge
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

10.  Humoral immunity in experimental Pneumocystis carinii infection. I. Serum and bronchial lavage fluid antibody responses in rats.

Authors:  P D Walzer; M E Rutledge
Journal:  J Lab Clin Med       Date:  1981-06
View more
  9 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Preservation of clonal heterogeneity of the Pneumocystis carinii-specific CD4 T cell repertoire in HIV infected, asymptomatic individuals.

Authors:  G Li Pira; D Fenoglio; L Bottone; P Terranova; E Pontali; F Caroli; M Seri; J-C Cailliez; G Koopman; R Accolla; F del Galdo; G Abbate; R de Palma; F Manca
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

3.  Usefulness of PCR for diagnosis of Pneumocystis carinii pneumonia in different patient groups.

Authors:  M Weig; H Klinker; B H Bögner; A Meier; U Gross
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen.

Authors:  S A Theus; D W Sullivan; P D Walzer; A G Smulian
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Isolation and characterization of a recombinant antigen of Pneumocystis carinii.

Authors:  A G Smulian; J R Stringer; M J Linke; P D Walzer
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii.

Authors:  O Kandil; J A Fishman; H Koziel; P Pinkston; R M Rose; H G Remold
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii.

Authors:  S A Theus; M J Linke; R P Andrews; P D Walzer
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

8.  Purification and characterization of a major human Pneumocystis carinii surface antigen.

Authors:  B Lundgren; G Y Lipschik; J A Kovacs
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp120) after immunization and natural infection.

Authors:  D J Fisher; F Gigliotti; M Zauderer; A G Harmsen
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.